Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity	ALG10 ALG10B	1.21e-05	2	70	2	GO:0106073
GeneOntologyMolecularFunction	lipopolysaccharide immune receptor activity	SCARB1 TLR4	1.80e-04	6	70	2	GO:0001875
GeneOntologyMolecularFunction	pattern recognition receptor activity	SCARB1 TLR4 TLR9	2.49e-04	35	70	3	GO:0038187
GeneOntologyBiologicalProcess	developmental process involved in reproduction	GMCL1 GMCL2 MSH6 PATZ1 WNT5A CSNK2A2 KAT8 TTC12 RXFP2 GATA4 AHR PAQR5 TLR9 CSMD1 CLOCK	1.11e-05	1235	69	15	GO:0003006
GeneOntologyBiologicalProcess	columnar/cuboidal epithelial cell differentiation	WNT5A GATA2 GATA4 EXT1 TLR9 CLOCK	1.83e-05	164	69	6	GO:0002065
GeneOntologyBiologicalProcess	detection of molecule of bacterial origin	SCARB1 TLR4 TLR9	1.94e-05	16	69	3	GO:0032490
GeneOntologyBiologicalProcess	male gonad development	PATZ1 WNT5A RXFP2 GATA4 TLR9 CSMD1	2.31e-05	171	69	6	GO:0008584
GeneOntologyBiologicalProcess	development of primary male sexual characteristics	PATZ1 WNT5A RXFP2 GATA4 TLR9 CSMD1	2.39e-05	172	69	6	GO:0046546
GeneOntologyBiologicalProcess	gonad development	PATZ1 WNT5A RXFP2 GATA4 AHR TLR9 CSMD1	5.40e-05	292	69	7	GO:0008406
GeneOntologyBiologicalProcess	male sex differentiation	PATZ1 WNT5A RXFP2 GATA4 TLR9 CSMD1	5.41e-05	199	69	6	GO:0046661
GeneOntologyBiologicalProcess	development of primary sexual characteristics	PATZ1 WNT5A RXFP2 GATA4 AHR TLR9 CSMD1	6.01e-05	297	69	7	GO:0045137
GeneOntologyBiologicalProcess	columnar/cuboidal epithelial cell development	WNT5A GATA2 TLR9 CLOCK	8.42e-05	69	69	4	GO:0002066
GeneOntologyBiologicalProcess	sexual reproduction	GMCL1 GMCL2 MSH6 PATZ1 WNT5A CSNK2A2 KAT8 TTC12 RXFP2 GATA4 PAQR5 DCST2 CLOCK CDC23	9.43e-05	1312	69	14	GO:0019953
GeneOntologyBiologicalProcess	multicellular organismal reproductive process	GMCL1 GMCL2 MSH6 PATZ1 CSNK2A2 KAT8 TTC12 RXFP2 GATA4 PAQR5 DCST2 CSMD1 CLOCK	1.43e-04	1194	69	13	GO:0048609
GeneOntologyBiologicalProcess	sex differentiation	PATZ1 WNT5A RXFP2 GATA4 AHR TLR9 CSMD1	1.73e-04	352	69	7	GO:0007548
GeneOntologyBiologicalProcess	T cell chemotaxis	CCR2 CXCR3 WNT5A	1.82e-04	33	69	3	GO:0010818
GeneOntologyBiologicalProcess	detection of external biotic stimulus	SCARB1 TLR4 TLR9	1.82e-04	33	69	3	GO:0098581
GeneOntologyBiologicalProcess	post-embryonic hemopoiesis	KAT8 AHR	2.29e-04	7	69	2	GO:0035166
GeneOntologyBiologicalProcess	detection of lipopolysaccharide	SCARB1 TLR4	2.29e-04	7	69	2	GO:0032497
GeneOntologyBiologicalProcess	wound healing	CCR2 WNT5A SCARB1 TLR4 GATA2 GATA4 EXT1 VAV2	2.34e-04	493	69	8	GO:0042060
GeneOntologyBiologicalProcess	glandular epithelial cell differentiation	WNT5A GATA2 EXT1 CLOCK	2.46e-04	91	69	4	GO:0002067
GeneOntologyBiologicalProcess	reproductive structure development	PATZ1 WNT5A RXFP2 GATA4 AHR TLR9 CSMD1	2.89e-04	383	69	7	GO:0048608
GeneOntologyBiologicalProcess	reproductive system development	PATZ1 WNT5A RXFP2 GATA4 AHR TLR9 CSMD1	3.13e-04	388	69	7	GO:0061458
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR5T3 SCARB1 TLR4 OR52N4 OR1E3 OR10J4 TLR9 OR9G9	3.53e-04	524	69	8	GO:0009593
GeneOntologyBiologicalProcess	gamete generation	GMCL1 GMCL2 MSH6 PATZ1 CSNK2A2 KAT8 TTC12 RXFP2 GATA4 PAQR5 CLOCK	3.90e-04	982	69	11	GO:0007276
GeneOntologyBiologicalProcess	positive regulation of type II interferon production	CCR2 WNT5A TLR4 TLR9	3.95e-04	103	69	4	GO:0032729
GeneOntologyBiologicalProcess	glandular epithelial cell development	WNT5A GATA2 CLOCK	4.02e-04	43	69	3	GO:0002068
GeneOntologyBiologicalProcess	positive regulation of inflammatory response	CCR2 WNT5A TLR4 TLR9 CLOCK	4.71e-04	193	69	5	GO:0050729
GeneOntologyBiologicalProcess	detection of biotic stimulus	SCARB1 TLR4 TLR9	4.91e-04	46	69	3	GO:0009595
Domain	Alg10	ALG10 ALG10B	1.27e-05	2	67	2	IPR016900
Domain	Relaxin_rcpt	RXFP2 RXFP1	1.27e-05	2	67	2	IPR008112
Domain	DIE2_ALG10	ALG10 ALG10B	1.27e-05	2	67	2	PF04922
Domain	MAM	MALRD1 MAMDC2 NPNT	2.89e-05	17	67	3	SM00137
Domain	MAM	MALRD1 MAMDC2 NPNT	3.46e-05	18	67	3	PF00629
Domain	MAM_dom	MALRD1 MAMDC2 NPNT	3.46e-05	18	67	3	IPR000998
Domain	MAM_2	MALRD1 MAMDC2 NPNT	3.46e-05	18	67	3	PS50060
Domain	BTB	GMCL1 GMCL2 PATZ1 KLHL15 KCNS3 ZBTB18	4.52e-05	180	67	6	SM00225
Domain	BTB/POZ_dom	GMCL1 GMCL2 PATZ1 KLHL15 KCNS3 ZBTB18	5.26e-05	185	67	6	IPR000210
Domain	TIR	IL1RAPL2 TLR4 TLR9	5.60e-05	21	67	3	SM00255
Domain	TIR	IL1RAPL2 TLR4 TLR9	6.47e-05	22	67	3	PF01582
Domain	-	IL1RAPL2 TLR4 TLR9	7.42e-05	23	67	3	3.40.50.10140
Domain	TIR	IL1RAPL2 TLR4 TLR9	8.46e-05	24	67	3	PS50104
Domain	TIR_dom	IL1RAPL2 TLR4 TLR9	9.59e-05	25	67	3	IPR000157
Domain	BTB	GMCL1 GMCL2 PATZ1 KLHL15 ZBTB18	1.07e-04	131	67	5	PF00651
Domain	BTB	GMCL1 GMCL2 PATZ1 KLHL15 ZBTB18	2.73e-04	160	67	5	PS50097
Domain	LDLR_class-A_CS	MALRD1 RXFP2 RXFP1	3.96e-04	40	67	3	IPR023415
Domain	Ldl_recept_a	MALRD1 RXFP2 RXFP1	5.62e-04	45	67	3	PF00057
Domain	SKP1/BTB/POZ	GMCL1 PATZ1 KLHL15 KCNS3 ZBTB18	5.85e-04	189	67	5	IPR011333
Domain	-	MALRD1 RXFP2 RXFP1	6.00e-04	46	67	3	4.10.400.10
Domain	LDLRA_1	MALRD1 RXFP2 RXFP1	6.80e-04	48	67	3	PS01209
Domain	AdipoR/HlyIII-related	PAQR5 PAQR6	6.83e-04	11	67	2	IPR004254
Domain	HlyIII	PAQR5 PAQR6	6.83e-04	11	67	2	PF03006
Domain	LDLRA_2	MALRD1 RXFP2 RXFP1	7.22e-04	49	67	3	PS50068
Domain	LDrepeatLR_classA_rpt	MALRD1 RXFP2 RXFP1	7.22e-04	49	67	3	IPR002172
Domain	LDLa	MALRD1 RXFP2 RXFP1	7.22e-04	49	67	3	SM00192
Domain	ZnF_GATA	GATA2 GATA4	8.18e-04	12	67	2	SM00401
Domain	Znf_GATA	GATA2 GATA4	1.29e-03	15	67	2	IPR000679
Domain	GATA	GATA2 GATA4	1.29e-03	15	67	2	PF00320
Domain	Chemokine_rcpt	CCR2 CXCR3	1.47e-03	16	67	2	IPR000355
Domain	GATA_ZN_FINGER_1	GATA2 GATA4	1.47e-03	16	67	2	PS00344
Domain	MAM_1	MAMDC2 NPNT	1.47e-03	16	67	2	PS00740
Domain	GATA_ZN_FINGER_2	GATA2 GATA4	1.47e-03	16	67	2	PS50114
Domain	PAS_fold_3	AHR CLOCK	3.06e-03	23	67	2	IPR013655
Domain	PAS_3	AHR CLOCK	3.06e-03	23	67	2	PF08447
Domain	LRR_8	TLR4 RXFP2 RXFP1 TLR9	3.32e-03	171	67	4	PF13855
Domain	PAS	AHR CLOCK	3.61e-03	25	67	2	PF00989
Domain	PAS_fold	AHR CLOCK	3.61e-03	25	67	2	IPR013767
Domain	Leu-rich_rpt_typical-subtyp	TLR4 RXFP2 RXFP1 TLR9	3.76e-03	177	67	4	IPR003591
Domain	LRR_TYP	TLR4 RXFP2 RXFP1 TLR9	3.76e-03	177	67	4	SM00369
Domain	PAC	AHR CLOCK	3.90e-03	26	67	2	IPR001610
Domain	PAC	AHR CLOCK	3.90e-03	26	67	2	SM00086
Domain	PAC	AHR CLOCK	3.90e-03	26	67	2	PS50113
Domain	PAS	AHR CLOCK	5.87e-03	32	67	2	SM00091
Domain	LRR	TLR4 RXFP2 RXFP1 TLR9	5.88e-03	201	67	4	PS51450
Domain	-	CLTCL1 TTC12 TRAPPC8 CDC23	6.52e-03	207	67	4	1.25.40.10
Domain	PAS	AHR CLOCK	6.60e-03	34	67	2	IPR000014
Domain	PAS	AHR CLOCK	6.60e-03	34	67	2	PS50112
Pubmed	Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.	CCR2 TLR4 TLR9	3.12e-08	4	70	3	22442158
Pubmed	Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.	CCR2 TLR4 TLR9	1.55e-07	6	70	3	22902233
Pubmed	The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.	CCR2 TLR4 TLR9	9.28e-07	10	70	3	32668198
Pubmed	The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes.	CCR2 TLR4 TLR9	1.27e-06	11	70	3	28978634
Pubmed	Commensal-driven immune zonation of the liver promotes host defence.	CCR2 CXCR3 TLR4	2.20e-06	13	70	3	33239787
Pubmed	IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.	TLR4 AHR TLR9	2.80e-06	14	70	3	23853597
Pubmed	The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.	TLR4 TLR9	3.99e-06	2	70	2	18092352
Pubmed	TLR-Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo.	TLR4 TLR9	3.99e-06	2	70	2	28426135
Pubmed	Acquisition of adult-like TLR4 and TLR9 responses during the first year of life.	TLR4 TLR9	3.99e-06	2	70	2	20442853
Pubmed	Assessment of TLR4 and TLR9 signaling and correlation with human papillomavirus status and histopathologic parameters in oral tongue squamous cell carcinoma.	TLR4 TLR9	3.99e-06	2	70	2	32173390
Pubmed	Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes.	CCR2 CXCR3	3.99e-06	2	70	2	14725563
Pubmed	Mouse germ cell-less as an essential component for nuclear integrity.	GMCL1 GMCL2	3.99e-06	2	70	2	12556490
Pubmed	Increased expression of Toll-like receptors 4 and 9 in human lung cancer.	TLR4 TLR9	3.99e-06	2	70	2	18763053
Pubmed	CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.	CCR2 CXCR3	3.99e-06	2	70	2	16033640
Pubmed	Alveolar bone loss in relation to toll-like receptor 4 and 9 genotypes and Porphyromonas gingivalis carriage.	TLR4 TLR9	3.99e-06	2	70	2	27492306
Pubmed	Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice.	RXFP2 RXFP1	3.99e-06	2	70	2	22028476
Pubmed	Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis.	TLR4 TLR9	3.99e-06	2	70	2	25400780
Pubmed	Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.	TLR4 TLR9	3.99e-06	2	70	2	21050493
Pubmed	TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis.	TLR4 TLR9	3.99e-06	2	70	2	32753695
Pubmed	Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.	TLR4 TLR9	3.99e-06	2	70	2	36563560
Pubmed	TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis.	TLR4 TLR9	3.99e-06	2	70	2	33910419
Pubmed	The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.	RXFP2 RXFP1	3.99e-06	2	70	2	22973049
Pubmed	Polymorphisms and expression of TLR4 and 9 in malaria in two ethnic groups of Assam, northeast India.	TLR4 TLR9	3.99e-06	2	70	2	22948021
Pubmed	Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitis.	TLR4 TLR9	3.99e-06	2	70	2	34416273
Pubmed	Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy.	TLR4 TLR9	3.99e-06	2	70	2	16779724
Pubmed	TLR9 2848 GA heterozygotic status possibly predisposes fetuses and newborns to congenital infection with human cytomegalovirus.	TLR4 TLR9	3.99e-06	2	70	2	25844529
Pubmed	Molecular cloning and genomic organization of mouse homologue of Drosophila germ cell-less and its expression in germ lineage cells.	GMCL1 GMCL2	3.99e-06	2	70	2	10448096
Pubmed	Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages.	TLR4 TLR9	3.99e-06	2	70	2	19923461
Pubmed	Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.	TLR4 TLR9	3.99e-06	2	70	2	12356687
Pubmed	Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.	TLR4 TLR9	3.99e-06	2	70	2	23651260
Pubmed	Gene Polymorphisms of TLR4 and TLR9 and Haemophilus influenzae Meningitis in Angolan Children.	TLR4 TLR9	3.99e-06	2	70	2	32967147
Pubmed	Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.	RXFP2 RXFP1	3.99e-06	2	70	2	19416161
Pubmed	Modeling the primary hormone-binding site of RXFP1 and RXFP2.	RXFP2 RXFP1	3.99e-06	2	70	2	19416162
Pubmed	Diverse Profiles of Toll-Like Receptors 2, 4, 7, and 9 mRNA in Peripheral Blood and Biopsy Specimens of Patients with Celiac Disease.	TLR4 TLR9	3.99e-06	2	70	2	30057921
Pubmed	The Impact of Circulating Mitochondrial DNA on Cardiomyocyte Apoptosis and Myocardial Injury After TLR4 Activation in Experimental Autoimmune Myocarditis.	TLR4 TLR9	3.99e-06	2	70	2	28618428
Pubmed	TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.	TLR4 TLR9	3.99e-06	2	70	2	25499923
Pubmed	Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.	TLR4 TLR9	3.99e-06	2	70	2	24719374
Pubmed	Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages.	TLR4 TLR9	3.99e-06	2	70	2	20843333
Pubmed	Associations of toll-like receptor 4 and 2 gene polymorphisms with susceptibility to ankylosing spondylitis: A meta-analysis.	TLR4 TLR9	3.99e-06	2	70	2	33369094
Pubmed	TLR9 and MyD88 are crucial for the development of protective immunity to malaria.	TLR4 TLR9	3.99e-06	2	70	2	22516959
Pubmed	Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.	TLR4 TLR9	3.99e-06	2	70	2	12515817
Pubmed	Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility.	TLR4 TLR9	3.99e-06	2	70	2	31365550
Pubmed	Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.	TLR4 TLR9	3.99e-06	2	70	2	22070100
Pubmed	Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population.	TLR4 TLR9	3.99e-06	2	70	2	17482427
Pubmed	Genetic variants of TLR4 and TLR9 are risk factors for chronic Helicobacter pylori infection in South Indian Tamils.	TLR4 TLR9	3.99e-06	2	70	2	27993530
Pubmed	Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.	RXFP2 RXFP1	3.99e-06	2	70	2	16051677
Pubmed	Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis.	TLR4 TLR9	3.99e-06	2	70	2	25889916
Pubmed	Toll-like receptor 9 deficiency impacts sensory and motor behaviors.	TLR4 TLR9	3.99e-06	2	70	2	23624295
Pubmed	[Association of Toll-like receptor gene with Crohn's disease in Koreans].	TLR4 TLR9	3.99e-06	2	70	2	20026892
Pubmed	Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.	TLR4 TLR9	3.99e-06	2	70	2	31278284
Pubmed	Critical role of TLR9 in acute graft-versus-host disease.	TLR4 TLR9	3.99e-06	2	70	2	18941203
Pubmed	Enhancing mucosal immunity by transient microbiota depletion.	CCR2 CXCR3	3.99e-06	2	70	2	32901029
Pubmed	Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.	TLR4 TLR9	3.99e-06	2	70	2	23021866
Pubmed	The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo.	TLR4 TLR9	3.99e-06	2	70	2	18641311
Pubmed	Association of TLR4 and TLR9 gene polymorphisms with cervical HR-HPV infection status in Chinese Han population.	TLR4 TLR9	3.99e-06	2	70	2	36915050
Pubmed	Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.	TLR4 TLR9	3.99e-06	2	70	2	35158151
Pubmed	TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.	TLR4 TLR9	3.99e-06	2	70	2	20810248
Pubmed	Stage-specific expression of mouse germ cell-less-1 (mGCL-1), and multiple deformations during mgcl-1 deficient spermatogenesis leading to reduced fertility.	GMCL1 GMCL2	3.99e-06	2	70	2	15700541
Pubmed	TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea.	TLR4 TLR9	3.99e-06	2	70	2	34216140
Pubmed	Association between TLR4 and TLR9 gene polymorphisms with development of pulmonary tuberculosis in Zahedan, southeastern Iran.	TLR4 TLR9	3.99e-06	2	70	2	23766695
Pubmed	TLR4 and TLR9 are induced in oral lichen planus.	TLR4 TLR9	3.99e-06	2	70	2	22672741
Pubmed	Association of TLR4 and TLR9 gene polymorphisms with the risk and progression of cervical lesions in HPV-infected women.	TLR4 TLR9	3.99e-06	2	70	2	37097031
Pubmed	TLR4 and TLR9 polymorphisms are not associated with either rheumatoid arthritis or systemic lupus erythematosus in Mexican patients.	TLR4 TLR9	3.99e-06	2	70	2	33939072
Pubmed	Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules.	RXFP2 RXFP1	3.99e-06	2	70	2	16963451
Pubmed	Using real time RT-PCR analysis to determine multiple gene expression patterns during XX and XY mouse fetal gonad development.	WNT5A SCARB1 GATA2 GATA4	4.41e-06	54	70	4	15533830
Pubmed	Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets.	WNT5A GATA2 GATA4	6.23e-06	18	70	3	15929941
Pubmed	Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.	CCR2 TLR4 TLR9	1.01e-05	21	70	3	27189410
Pubmed	A novel role for relaxin-2 in the pathogenesis of primary varicosis.	RXFP2 RXFP1	1.20e-05	3	70	2	22737225
Pubmed	TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.	TLR4 TLR9	1.20e-05	3	70	2	17914947
Pubmed	Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils.	TLR4 TLR9	1.20e-05	3	70	2	27505671
Pubmed	Expression of toll-like receptors on antigen-presenting cells in patients with falciparum malaria.	TLR4 TLR9	1.20e-05	3	70	2	17854755
Pubmed	A point mutation in the gene for asparagine-linked glycosylation 10B (Alg10b) causes nonsyndromic hearing impairment in mice (Mus musculus).	ALG10 ALG10B	1.20e-05	3	70	2	24303013
Pubmed	Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll-like receptor 4.	WNT5A TLR4	1.20e-05	3	70	2	24643512
Pubmed	Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.	TLR4 TLR9	1.20e-05	3	70	2	21368092
Pubmed	Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy.	GATA2 GATA4	1.20e-05	3	70	2	28381408
Pubmed	[Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations].	TLR4 TLR9	1.20e-05	3	70	2	20646633
Pubmed	Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.	TLR4 TLR9	1.20e-05	3	70	2	16371473
Pubmed	Toll-like receptor signaling in anti-cancer immunity.	TLR4 TLR9	1.20e-05	3	70	2	12630564
Pubmed	Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients.	TLR4 TLR9	1.20e-05	3	70	2	23425749
Pubmed	Systemically administered ligands of Toll-like receptor 2, -4, and -9 induce distinct inflammatory responses in the murine lung.	TLR4 TLR9	1.20e-05	3	70	2	21547259
Pubmed	CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling.	CXCR3 TLR4	1.20e-05	3	70	2	19187771
Pubmed	A pilot study on expression of toll like receptors (TLRs) in response to herpes simplex virus (HSV) infection in acute retinal pigment epithelial cells (ARPE) cells.	TLR4 TLR9	1.20e-05	3	70	2	25121361
Pubmed	Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.	CCR2 TLR9	1.20e-05	3	70	2	20093775
Pubmed	Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia.	TLR4 TLR9	1.20e-05	3	70	2	19933834
Pubmed	Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion.	TLR4 TLR9	1.20e-05	3	70	2	17371986
Pubmed	Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia.	TLR4 TLR9	1.20e-05	3	70	2	20804821
Pubmed	Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis.	TLR4 TLR9	1.20e-05	3	70	2	18275280
Pubmed	TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.	TLR4 TLR9	1.20e-05	3	70	2	20526283
Pubmed	Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.	CXCR3 TLR9	1.20e-05	3	70	2	27390897
Pubmed	Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.	TLR4 TLR9	1.20e-05	3	70	2	19539691
Pubmed	Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus/Wolbachia-induced keratitis.	TLR4 TLR9	1.20e-05	3	70	2	17875630
Pubmed	Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis.	TLR4 TLR9	1.20e-05	3	70	2	22662111
Pubmed	Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients.	TLR4 TLR9	1.20e-05	3	70	2	28255201
Pubmed	Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium.	TLR4 TLR9	1.20e-05	3	70	2	28988039
Pubmed	Association between genetic variants of TLR2, TLR4, TLR9 and schizophrenia.	TLR4 TLR9	1.20e-05	3	70	2	37718198
Pubmed	Essential genes Ptgs2, Tlr4, and Ccr2 regulate neuro-inflammation during the acute phase of cerebral ischemic in mice.	CCR2 TLR4	1.20e-05	3	70	2	37563282
Pubmed	Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.	RXFP2 RXFP1	1.20e-05	3	70	2	23024363
Pubmed	Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.	TLR4 TLR9	1.20e-05	3	70	2	29883450
Pubmed	Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice.	TLR4 TLR9	1.20e-05	3	70	2	15538945
Pubmed	TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.	TLR4 TLR9	1.20e-05	3	70	2	17599410
GeneFamily	Alpha-1,2-glucosyltransferases	ALG10 ALG10B	8.43e-06	2	53	2	448
GeneFamily	Relaxin family peptide receptors	RXFP2 RXFP1	5.04e-05	4	53	2	217
GeneFamily	CD molecules\|Toll like receptors	TLR4 TLR9	3.74e-04	10	53	2	948
GeneFamily	Progestin and adipoQ receptor family	PAQR5 PAQR6	4.56e-04	11	53	2	930
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	GMCL1 PATZ1 KLHL15 ZBTB18	6.38e-04	134	53	4	861
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATA2 GATA4	8.64e-04	15	53	2	82
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT8 CLOCK	1.11e-03	17	53	2	486
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLCD3 TMC7 ST6GALNAC3 DOCK9 GATA2 RXFP1	3.70e-07	183	68	6	ce8be9418b473ea94ec806edc7a2078cc30c1703
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	IL1RAPL2 ST6GALNAC3 AHR MBOAT2 SDHD	5.89e-06	168	68	5	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK9 SCARB1 GATA2 AHR ZBTB18	8.46e-06	181	68	5	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	9.91e-06	187	68	5	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.15e-05	193	68	5	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.15e-05	193	68	5	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.18e-05	194	68	5	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.18e-05	194	68	5	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.18e-05	194	68	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC3 DOCK9 GATA2 RXFP1 MBOAT2	1.24e-05	196	68	5	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 SCARB1 GATA2 RXFP1	1.24e-05	196	68	5	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC3 SCARB1 GATA2 RXFP1 MBOAT2	1.27e-05	197	68	5	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ST6GALNAC3 DOCK9 GATA2 RXFP1 CSMD1	1.31e-05	198	68	5	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	ST6GALNAC3 DOCK9 GATA2 RXFP1 CSMD1	1.34e-05	199	68	5	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC3 GATA2 PAQR5 RXFP1 PPFIA3	1.34e-05	199	68	5	fff88d2bba262583bb726900ae01e44954b72eb9
ToppCell	Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells\|Control_saline / Treatment groups by lineage, cell group, cell type	LEKR1 GATA2 GATA4 PAQR5 PAQR6	1.37e-05	200	68	5	58b25dc2d29e98354bfc8e8e161796c237c3dc23
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MALRD1 TRAM1L1 WNT5A PAQR6	7.18e-05	145	68	4	80684ec249fa445c1b35f94608a4a6824d53f2d9
ToppCell	343B-Epithelial_cells-Epithelial-E_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	MALRD1 TRAM1L1 WNT5A PAQR6	7.18e-05	145	68	4	cb534333fba44b241b14fb0d7b74e843f4e7f9f8
ToppCell	368C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CLTCL1 POLE SCARB1 RXFP1	9.53e-05	156	68	4	4877aabf647238c0279e497345b6a6d5ee07ef9c
ToppCell	368C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CLTCL1 POLE SCARB1 RXFP1	9.53e-05	156	68	4	1d681fa17e62815f5d5f90c86be3c248b38e011b
ToppCell	Control-MAIT\|World / Disease group and Cell class	CSNK2A2 KAT8 LEKR1 VAV2	1.13e-04	163	68	4	0ca4b835936b4f82217cbe57210c1dd90986c1d0
ToppCell	Multiple_Sclerosis-Other-HSPC\|Multiple_Sclerosis / Disease, Lineage and Cell Type	MALRD1 MAMDC2 GATA2 RXFP1	1.16e-04	164	68	4	6af5529507d695b347adee4be5ead70f56c9cf55
ToppCell	facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 TLR4 PAQR5 TLR9	1.21e-04	166	68	4	5c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCARB1 GATA2 AHR SERINC3	1.30e-04	169	68	4	41ad349806b279fbe1374b7e3cc7f146a11adb44
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCARB1 GATA2 AHR SERINC3	1.30e-04	169	68	4	42782c61592742190ab0cba8a94f8bdf9c278f90
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	POLE SCARB1 KLHL15 KCNS3	1.30e-04	169	68	4	ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9
ToppCell	NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PATZ1 WNT5A DOCK9 EXT1	1.33e-04	170	68	4	adf73bdc049d508f8873c22539db2ca92052a97b
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMC7 ST6GALNAC3 DOCK9 CSMD1	1.36e-04	171	68	4	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	NS-critical-d_0-4-Epithelial-FOXN4+\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PLCD3 ANKEF1 RTTN DCST2	1.39e-04	172	68	4	a00bb44d33658cb3a98accd6b60f3ce964c425b4
ToppCell	Control-MAIT\|Control / Disease group and Cell class	CSNK2A2 LEKR1 TLR4 VAV2	1.39e-04	172	68	4	552bc62e8e8bb0ac1cd0452f4410a3af087787eb
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CXCR3 ERICH3 DNAJC16 POLE	1.39e-04	172	68	4	dd9ba79e1542fe9fa2c319077d83dd3fc0158f46
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 DOCK9 GATA2 PPFIA3	1.42e-04	173	68	4	ec88e871b49331fca59bc610a8ae58e2d5e76bc1
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 DOCK9 GATA2 PPFIA3	1.42e-04	173	68	4	22200fe74e33e2beae0eed289ca8476bbc0b1b2d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL1RAPL2 OR52N4 RXFP1 DNAH14	1.42e-04	173	68	4	4ec147479b359cce1975d57a50ee1437a0e1e663
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ST6GALNAC3 DOCK9 GATA2 AHR	1.45e-04	174	68	4	cb0109661e8c9ca04d67d33f2d926f0e649bf67d
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	MSH6 CXCR3 SCARB1 CSMD1	1.45e-04	174	68	4	b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GMCL1 PAQR6 PRORP MBOAT2	1.45e-04	174	68	4	c58328c2f262506a4518f49f148e29874faf9171
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRAM1L1 ST6GALNAC3 DOCK9 GATA2	1.58e-04	178	68	4	4b3ea0921bc598ebb9f63780ecdf8ad4349f3666
ToppCell	368C-Endothelial_cells-Endothelial-E\|368C / Donor, Lineage, Cell class and subclass (all cells)	DOCK9 SCARB1 GATA2 RXFP1	1.65e-04	180	68	4	8ab16a0b9053bffc07b569a4f9e71749f56dde7e
ToppCell	368C-Endothelial_cells-Endothelial-E-\|368C / Donor, Lineage, Cell class and subclass (all cells)	DOCK9 SCARB1 GATA2 RXFP1	1.65e-04	180	68	4	394cd465b88429b70eebb2957480dffcbc51cfe7
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5A GATA2 AHR PAQR5	1.72e-04	182	68	4	e6a734fb29105093d4cbfc3d0619a825b66da034
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5A GATA2 AHR PAQR5	1.72e-04	182	68	4	ccc313ecc0bfd8e2c6bb83a565b427b2310485ec
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5A GATA2 AHR PAQR5	1.72e-04	182	68	4	b9f758961fb4a586ae86fa0b25edb8ce4616d644
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5A GATA4 KCNS3 CSMD1	1.76e-04	183	68	4	b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0
ToppCell	droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5A GATA4 KCNS3 CSMD1	1.76e-04	183	68	4	19e7be1cfdd111bfb840532a6f7c780345dffccf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL1RAPL2 TRPV6 RXFP1 MBOAT2	1.80e-04	184	68	4	ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	1.83e-04	185	68	4	c3105978d971da7d0fad1a717ee29afee5ed6357
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	MALRD1 ST6GALNAC3 WNT5A NPNT	1.83e-04	185	68	4	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	1.83e-04	185	68	4	4cfef50aeed5b3000ce5e864a41c13740b8267b1
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SCARB1 ANKEF1 GATA4 VAV2	1.83e-04	185	68	4	1d874608aa2062024323512f68889219471b2f00
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	URB1 DOCK9 ALG10 ALG10B	1.83e-04	185	68	4	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC3 GATA2 RXFP1 MBOAT2	1.83e-04	185	68	4	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	1.83e-04	185	68	4	09256c6f42f59b7eb89160b2ea706172a5b743be
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 RXFP1 CSMD1	1.83e-04	185	68	4	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL1RAPL2 TRPV6 RXFP1 MBOAT2	1.87e-04	186	68	4	77b09af860183606a1775eba921e2071e4a7dd4e
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	ST6GALNAC3 DOCK9 GATA2 RXFP1	1.87e-04	186	68	4	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 AHR	1.91e-04	187	68	4	3548a9914c2b2f5d805798ce22ab26eab6d03897
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ST6GALNAC3 DOCK9 GATA2 EXT1	1.91e-04	187	68	4	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 AHR	1.91e-04	187	68	4	f4de4b7af1fdfbd628b1f509c060c1079d2e5437
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK9 GATA2 AHR RXFP1	1.91e-04	187	68	4	106f50ad85a92403037214f0e94702230284837f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Endothelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 AHR	1.91e-04	187	68	4	81754e965848b718be20ee97ce072ce426938a69
ToppCell	P03-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SCARB1 GATA2 AHR SERINC3	1.91e-04	187	68	4	55618ceec367c1c51ed5c447063d7fbd5c7e0808
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	ST6GALNAC3 DOCK9 RXFP1 CSMD1	1.91e-04	187	68	4	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC3 GATA2 RXFP1 MBOAT2	1.95e-04	188	68	4	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WNT5A GATA4 KCNS3 CSMD1	1.99e-04	189	68	4	cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WNT5A GATA4 KCNS3 CSMD1	1.99e-04	189	68	4	102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 SERINC3	1.99e-04	189	68	4	a3f6ebd1622d36d114e42f6e0618d7b2fe8b9a2f
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC3 DOCK9 GATA2 MBOAT2	1.99e-04	189	68	4	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 SERINC3	1.99e-04	189	68	4	d86455cf20769d70d62e2c1dd92cbc93c67aada5
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 GATA2 CSMD1	1.99e-04	189	68	4	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ST6GALNAC3 DOCK9 GATA4 CSMD1	1.99e-04	189	68	4	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL2 GATA2 MBOAT2 VAV2	1.99e-04	189	68	4	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 SERINC3	1.99e-04	189	68	4	84036d1257f6b18f47cfc7ac5e6ed6ea3553c235
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WNT5A GATA4 KCNS3 CSMD1	1.99e-04	189	68	4	6e83bf855d4771885b60bb8992df2f9b508eef97
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ST6GALNAC3 DOCK9 GATA2 RXFP1	2.03e-04	190	68	4	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	PND01-Endothelial-Endothelial_blood-vessel\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCARB1 GATA2 AHR SERINC3	2.03e-04	190	68	4	2803eb02209591a63fe13e834e4e0f8014e1aa34
ToppCell	E17.5-Endothelial\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SCARB1 GATA2 AHR SERINC3	2.03e-04	190	68	4	4fb76195ec9d6e0260a628eef6c2b3705acce787
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 GATA2 MBOAT2	2.03e-04	190	68	4	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC3 DOCK9 RXFP1 CSMD1	2.03e-04	190	68	4	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CCR2 CXCR3 RXFP1 TLR9	2.03e-04	190	68	4	d06800ec9f6065c1cc536ed99e8569732272a94f
ToppCell	10x5'v1-week_14-16-Myeloid_DC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CCR2 CXCR3 RXFP1 TLR9	2.03e-04	190	68	4	485073e831afebdb393c7f4b622504d43d1b778b
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK9 GATA2 AHR RXFP1	2.07e-04	191	68	4	edfd5eeff69b5de19c5df3d899e42acd7e015913
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC3 DOCK9 RXFP1 CSMD1	2.07e-04	191	68	4	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	PND01-Endothelial\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCARB1 GATA2 AHR SERINC3	2.07e-04	191	68	4	96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL2 GATA2 TRPV6 VAV2	2.11e-04	192	68	4	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	DOCK9 PAQR5 DNAH14 NPNT	2.11e-04	192	68	4	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	facs-MAT-Fat-24m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 PAQR5	2.16e-04	193	68	4	ba9a47e2dc01efa6d2a99b1631d4951fac2648d4
ToppCell	facs-MAT-Fat-24m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 PAQR5	2.16e-04	193	68	4	724bb613fa434add5b1c5586b629328f819fbdfe
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC3 GATA2 RXFP1 MBOAT2	2.16e-04	193	68	4	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	facs-MAT-Fat-3m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	2.16e-04	193	68	4	b32533afeff1905e188becaa09079e9699722e4b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLCD3 TMC7 IL1RAPL2 AHR	2.16e-04	193	68	4	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	facs-MAT-Fat-3m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	2.16e-04	193	68	4	2ff573ba2c74583ed1cb071a3bbc01bb71117e5f
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCARB1 GATA2 AHR SERINC3	2.16e-04	193	68	4	30254658a2023ea9808cdd786530b966a1446418
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK9 GATA2 AHR RXFP1	2.16e-04	193	68	4	72d20ee257149b238016b44d183ce3fc24b8f621
ToppCell	facs-MAT-Fat-3m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GALNAC3 DOCK9 SCARB1 GATA2	2.16e-04	193	68	4	e164f6403a8b541ced08a6feec915d2e855036ea
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK9 SCARB1 GATA2 RXFP1	2.16e-04	193	68	4	ff6e6b825d6c88148216c601580be3c28851ab5c
ToppCell	facs-MAT-Fat-24m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK9 SCARB1 GATA2 PAQR5	2.16e-04	193	68	4	737e540c72a3cfe8dbd4c0f139f7d729a166793a
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK9 GATA2 AHR RXFP1	2.20e-04	194	68	4	3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK9 GATA2 AHR RXFP1	2.20e-04	194	68	4	8c88a0ddd61ad900426e312ca4ab13061c0380b8
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ST6GALNAC3 DOCK9 GATA2 EXT1	2.20e-04	194	68	4	b6cc849fa08599bff9839ef382d190cc964e273e
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A	URB1 DNAJC16 PATZ1 KAT8 PPFIA3 VAV2 TBC1D17	2.31e-06	198	69	7	3472_DN
Drug	Iocetamic acid [16034-77-8]; Down 200; 6.6uM; HL60; HT_HG-U133A	CXCR3 DNAJC16 DOCK9 SCARB1 GATA4 APBA3 VAV2	2.31e-06	198	69	7	3022_DN
Drug	3-nitroperylene	KAT8 AHR	9.05e-06	2	69	2	CID000062743
Disease	mastitis (biomarker_via_orthology)	TLR4 TLR9	5.08e-06	2	67	2	DOID:10690 (biomarker_via_orthology)
Disease	Cardiovascular Abnormalities	KAT8 GATA2 DDX6	6.13e-06	16	67	3	C0243050
Disease	Pneumonia	CCR2 CXCR3 TLR4 AHR	7.05e-06	54	67	4	C0032285
Disease	Pneumonitis	CCR2 CXCR3 TLR4 AHR	7.05e-06	54	67	4	C3714636
Disease	Lobar Pneumonia	CCR2 CXCR3 TLR4 AHR	7.05e-06	54	67	4	C0032300
Disease	Experimental Lung Inflammation	CCR2 CXCR3 TLR4 AHR	7.05e-06	54	67	4	C0887898
Disease	dermatomyositis (is_marker_for)	CCR2 TLR4 TLR9	7.44e-06	17	67	3	DOID:10223 (is_marker_for)
Disease	Long Qt Syndrome 2	ALG10 ALG10B	1.52e-05	3	67	2	C3150943
Disease	alcoholic pancreatitis	DNAJC16 TTC12 TRPV6 MBOAT2	7.47e-05	98	67	4	EFO_1002013
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10 ALG10B	7.57e-05	6	67	2	DOID:0050563 (implicated_via_orthology)
Disease	sleep latency	MALRD1 CSNK2A2 CSMD1	8.23e-05	37	67	3	EFO_0005280
Disease	ovarian cancer (implicated_via_orthology)	MSH6 POLE	1.41e-04	8	67	2	DOID:2394 (implicated_via_orthology)
Disease	Inflammation	CXCR3 TLR4 AHR TLR9	2.03e-04	127	67	4	C0021368
Disease	cutaneous leishmaniasis (is_marker_for)	TLR4 TLR9	2.26e-04	10	67	2	DOID:9111 (is_marker_for)
Disease	allergic conjunctivitis (is_marker_for)	TLR4 TLR9	2.26e-04	10	67	2	DOID:11204 (is_marker_for)
Disease	mismatch repair cancer syndrome (is_implicated_in)	MSH6 POLE	3.30e-04	12	67	2	DOID:0112182 (is_implicated_in)
Disease	asthma (is_implicated_in)	CCR2 CXCR3 TLR4 TLR9	4.56e-04	157	67	4	DOID:2841 (is_implicated_in)
Disease	circadian rhythm	DNAJC16 GATA4 CSMD1 ALG10B	5.25e-04	163	67	4	EFO_0004354
Disease	Contact Dermatitis	CXCR3 TLR4 AHR	5.73e-04	71	67	3	C0011616
Disease	Contact hypersensitivity	CXCR3 TLR4 AHR	5.73e-04	71	67	3	C0162351
Disease	response to triptolide, cytotoxicity measurement	PPIL3 CSMD1	5.97e-04	16	67	2	EFO_0006952, EFO_0007662
Disease	allergic rhinitis (is_marker_for)	TLR4 TLR9	6.76e-04	17	67	2	DOID:4481 (is_marker_for)
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR4 TLR9	6.76e-04	17	67	2	DOID:8677 (biomarker_via_orthology)
Disease	Malignant neoplasm of endometrium	MSH6 POLE	7.59e-04	18	67	2	C0007103
Disease	sinusitis (is_marker_for)	TLR4 TLR9	7.59e-04	18	67	2	DOID:0050127 (is_marker_for)
Disease	Carcinoma in situ of endometrium	MSH6 POLE	7.59e-04	18	67	2	C0346191
Disease	leptin measurement	LEKR1 ALG10 ALG10B	8.41e-04	81	67	3	EFO_0005000
Disease	Lung Injury	TLR4 AHR	1.04e-03	21	67	2	C0273115
Disease	Chronic Lung Injury	TLR4 AHR	1.04e-03	21	67	2	C2350344
Disease	Colorectal Carcinoma	GMCL2 MSH6 POLE TLR4 GATA4 CCAR1 TLR9	1.06e-03	702	67	7	C0009402
Disease	amblyopia	MALRD1 TLR4	1.14e-03	22	67	2	MONDO_0001020
Disease	QRS duration, response to sulfonylurea	DOCK9 CSMD1	1.25e-03	23	67	2	EFO_0005055, EFO_0007922
Disease	Behcet Syndrome	TLR4 AHR	1.36e-03	24	67	2	C0004943
Disease	interstitial lung disease (is_marker_for)	CCR2 TLR9	1.47e-03	25	67	2	DOID:3082 (is_marker_for)
Disease	acute necrotizing pancreatitis (biomarker_via_orthology)	TLR4 TLR9	1.59e-03	26	67	2	DOID:0080998 (biomarker_via_orthology)
Disease	anogenital venereal wart (is_marker_for)	TLR4 TLR9	1.59e-03	26	67	2	DOID:11168 (is_marker_for)
Disease	psychosis predisposition measurement	TMC7 CSMD1	1.59e-03	26	67	2	EFO_0008337
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	LEKR1 DCST2 CLOCK	1.78e-03	105	67	3	EFO_0007788, EFO_0008007, EFO_0008343
Disease	opioid dependence	TMC7 ST6GALNAC3 EXT1 CSMD1	2.09e-03	237	67	4	EFO_0005611

Protein segments in the cluster

Peptide	Gene	Start	Entry
GYQFIHAADMLYCAE	AHR	321	P35869
LGYMHCCLNPLLYAF	CXCR3	306	P49682
AAYNSLMDKHLAGYF	ERICH3	11	Q5RHP9
QLGYSCFYIHAKMRQ	DDX6	356	P26196
LHGCNSKKAYFLYMY	CDC23	106	Q9UJX2
MSILYHCKKGFYLLG	CSMD1	2821	Q96PZ7
LMAFVYFDQSHCGYL	CCAR1	926	Q8IX12
YKMLCHVFYAEDAQL	APBA3	326	O96018
HYAAMGGFADCCKYI	ANKEF1	256	Q9NU02
LFAYLMCLYGNHKTS	ALG10B	161	Q5I7T1
YFNYHDVGICKAVAM	SDHD	141	O14521
LHKIYLCQSGYFSSM	GMCL1	121	Q96IK5
SMSKNARHICYFLDY	PAQR5	106	Q9NXK6
CLRFHYAIYGFLKMS	MAMDC2	411	Q7Z304
MVGNCGLLYLIHYED	OR52N4	41	Q8NGI2
YCGVSYLILHEFKAM	LEKR1	26	Q6ZMV7
ENMHNYCFVFALGYL	MBOAT2	96	Q6ZWT7
FDLMYIGGKYQCHDI	NPNT	201	Q6UXI9
YMKYEKSYRFHLGQC	KAT8	216	Q9H7Z6
SLHYGIMCLKRLNYD	PPFIA3	1006	O75145
GYVLALNGHKKYFCL	DNAJC16	696	Q9Y2G8
NFYYTGKLHVMEELC	KCNS3	81	Q9BQ31
LAHKCILNSFYGYVM	POLE	806	Q07864
MRHICYFLDYGALSL	PAQR6	111	Q6TCH4
KGCYKFLMYFLLASN	OR9G9	191	P0C7N8
CYKVGKFYELYHMDA	MSH6	426	P52701
QVCGKYLRAAYMADH	PATZ1	471	Q9HBE1
NCKIIFHYHMYGNGI	MALRD1	1381	Q5VYJ5
TGHYLCNACGLYHKM	GATA2	311	P23769
YLCNACGLYHKMNGI	GATA4	236	P43694
YARCFHKMISYNGKL	KLHL15	476	Q96M94
CLHQFQYMGKRYIAR	DOCK9	1341	Q9BZ29
KYDYREMLHNATFCL	EXT1	321	Q16394
AMCKLFTGLYHIGYF	CCR2	111	P41597
FYMYELLKALDYCHS	CSNK2A2	136	P19784
MGLVNAYSHKFIKYC	DNAH14	676	Q0VDD8
QAYHLCYVLMPFKLA	DCST2	226	Q5T1A1
ECFLLAAMAYDHYVA	OR5T3	141	Q8NGG3
DCLAQMYFHLFYGVL	OR1E3	96	Q8WZA6
NKCFLLTAMGYDHYV	OR10J4	111	P0C629
LMLACYAGHLDVVKY	FANK1	181	Q8TC84
FYEHLNQMVKHCYLG	RTTN	1486	Q86VV8
KCYNIELMLFYRQHF	IL1RAPL2	376	Q9NP60
LHKIYLCQSGYFSSM	GMCL2	121	Q8NEA9
TFLLAMDACYGIHVY	ST6GALNAC3	221	Q8NDV1
MKNLSHIYFKNFRYC	RXFP2	376	Q8WXD0
MHYAQYVLLALGCVL	SCARB1	441	Q8WTV0
DLLVKYLYLCVFHMQ	PRORP	176	O15091
CSYMGHFDLLNYFAI	SF3B5	41	Q9BWJ5
HMKLICESLYASGYR	URB1	131	O60287
LFAYLMCLYGNHKTS	ALG10	161	Q5BKT4
EHLMQYGKGKSCYYR	CLOCK	326	O15516
KHQLMEFRCIAAYLY	CLTCL1	1501	P53675
NDILLTYCMYHFDLG	TBC1D17	401	Q9HA65
HYFVELLSHMCGLFY	TRAM1L1	226	Q8N609
LHALRFLFMDGNCYY	TLR9	166	Q9NR96
GCAHLENYALKMFLY	VTA1	86	Q9NP79
MYAYLLFKECDHSNN	PLCD3	221	Q8N3E9
YYNGCIFHRNIKGFM	PPIL3	36	Q9H2H8
VLASCSMYFHLFYKD	ZBTB18	41	Q99592
FACQMYNLLLSYDRH	TRPV6	251	Q9H1D0
LMNLSHIYFKKFQYC	RXFP1	366	Q9HBX9
FYMLHCGTALYNNLL	SRRD	216	Q9UH36
KLCHLYQDHMQYIGE	WNT5A	81	P41221
VQYSYSLFHLMLCLA	SERINC3	401	Q13530
AYFHMGKANLALKNY	TTC12	176	Q9H892
MADLCFLVQHYDLAY	TRAPPC8	426	Q9Y2L5
FKERLLIYGEYCSHM	VAV2	276	P52735
VYKFYFHLMLLAGCI	TLR4	651	O00206
CLIMFYFIALAGAHK	TMC7	676	Q7Z402